戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  strength and base of support during a usual walk.
2  and augmentation index up to 26 h after the walk.
3  at a faster pace, or taking longer-duration walks.
4 of landing probabilities of different length walks.
5 e lateral diffusion from the expected random walks.
6 e collision probabilities of multiple random walks.
7  calculating the coalescence times of random walks.
8 lf-reported subjective estimates of distance walked.
9 ion of neurons with a role in the control of walking.
10 tates relative to the microtubule (MT) while walking.
11 rectionality) but show random bi-directional walking.
12 that was more widespread at rest than during walking.
13 striatum) increased, most prominently during walking.
14 t and adapt to perturbations delivered while walking.
15 eases their risk to fall on their back while walking.
16  circuit for internally monitoring voluntary walking.
17  increased pronation/supination, and knuckle-walking.
18 hin each limb, to velocity-matched tied-belt walking.
19 the signatures of these relationships during walking.
20 these cells could be used to control forward walking.
21 d, in-bed activity, out-of-bed activity, and walking.
22 ely 13-34 strides) after onset of split-belt walking.
23                 In just 1 min of crawling or walking, 10(3)-10(4) resuspended FBAPs can deposit in th
24            Primary outcomes were pain during walking (11-point numerical rating scale) and physical f
25  speed was assessed by asking respondents to walk 2.5 m at their normal walking pace.
26  2 in 3 individuals with cerebral palsy will walk, 3 in 4 will talk, and 1 in 2 will have normal inte
27 correspond to locomotory differences: bottom-walking [5, 6] placodonts have proportionally larger lab
28 ity of affected individuals never learned to walk (68%).
29 approach is suitable to quantify qualitative walking abnormalities related to CNS circuit dysfunction
30 ls were used to compare times to standing or walking across feeding categories while adjusting for pa
31 n factor (AF): 0.93; 95% CI: 0.87, 0.99] and walking (AF: 0.93; 95% CI: 0.88, 0.98) 7% faster than di
32 eloped 'asymmetry linker-mediated nested PCR walking' (ALN-walking) for CNV breakpoint sequencing in
33 es that chromosome numbers evolve via random walk along branches of the phylogeny.
34 ld show that the remaining podocytes did not walk along GBM during 24 h.
35 ls making regenerative processes by podocyte walking along the GBM very unlikely.
36 e plasma membrane, where dynein captures and walks along astral microtubules to help orient the mitot
37  disassembly at the other end, so that Vps4 'walks' along ESCRT-III until it encounters the ordered N
38 on the provably efficient hit-and-run random walk and crucially uses a preprocessing step to round th
39  than functional measures including 6-minute walk and supine-to-stand tests.
40  exaggerated EPR, sometimes report pain when walking and are at risk for cardiac arrthymias.
41 y feedback to the spinal motor system during walking and are required for the production of a fluid l
42                      Pedometers can increase walking and moderate-to-vigorous physical activity (MVPA
43 scle activity was retained during split-belt walking and was similar, within each limb, to velocity-m
44 comes included self-reported caloric intake, walking, and moderate physical activity.
45 ed DNA with one leg and two foot domains for walking, and one arm and one hand domain for picking up
46 l for biological investigations by imaging a walking appendage of Euperipatoides rowelli, a represent
47 n displays a pretelsonic segment bearing non-walking appendages, features as-yet known in all vicissi
48 ails including the chelicerae, five pairs of walking appendages, opisthosomal appendages with book gi
49               On one time scale, dynamics of walking are consistent over hundreds of milliseconds, al
50              Thus, other concepts to restore walking are needed.
51 encourage active travel (i.e., bicycling and walking) are promising strategies for designing health-p
52  collision risk when walking for recreation, walking at a faster pace, or taking longer-duration walk
53 tes of 1.57 +/- 0.32 g min(-1) during 2 h of walking at approximately 80% VO2 peak .
54 ore of 2 [ie, he had to stop for breath when walking at his own pace on level ground]).
55  with right-foot preference during treadmill walking at speeds of 1.1, 1.4 and 1.7 m/s.
56 also increased the oxygen (O2 ) cost of race walking at velocities relevant to real-life race perform
57 ible [9-12] and can alternatively consist of walking backward away from the perceived threat [11], wh
58 ward walking via MDNs and that turning while walking backward might reflect asymmetric activation of
59 show that this capacity is undiminished when walking backward while dragging a heavy food item [3-5].
60                                   Ants often walk backwards to drag large prey to their nest.
61 rtant mechanistic neuromuscular insight into walking balance control and important reference values f
62                          We present a random walk-based growth model capable of predicting individual
63 tal data are explained by a family of random-walk-based models and probabilistic analytical approxima
64 sity estimation for robot swarms, and random walk-based sampling for sensor networks.
65 n to the treadmill paradigm with a tethered, walking bee was successful as bees exhibited robust disc
66 up) the median percentage change in distance walked between baseline and 6-month follow-up examinatio
67 e examined associations between individuals' walking bouts and walking risk, measured as mean exposur
68                                              Walking bouts were ascertained through integrated accele
69  frequency of hospitalizations, inability to walk, bradykinesia, scoliosis, gastrostomy feeding, age
70 delay during early development (later age at walking), but they were less impaired on certain measure
71                        The detailed basis of walking by dimeric molecules of kinesin along microtubul
72 atients returning to preoperative functional walking capacity (6-min walk test) at 4 weeks after surg
73 ranscutaneous oxygen tension, rest pain, and walking capacity after cell therapy.
74 s no between-group difference in recovery of walking capacity at 4 weeks after surgery [OR 0.77 (95%
75 , sustained an unexplained fall, and started walking cautiously.
76  major coordination deficits during the beam-walking challenge and were unable to cross the beam.
77             Exercise alone improved 6-minute walk compared with attention control + placebo (mean dif
78 creased slightly during exoskeleton-assisted walking compared to baseline, while knee flexor activity
79 n on one or both ankles, during a variety of walking conditions, during running, and when optimizing
80  results that vestibular sensory input while walking could be affected through mastoid vibration (MV)
81  Participants travelled to and from games by walking, cycling, car, bus, train or taxi.
82                            Both crawling and walking delivered a significant number of resuspended FB
83                                              Walking difficulties were recognized around their fortie
84                                              Walking disability and NSAIDs use have been postulated a
85 rtality into indirect and direct effects via walking disability and use of NSAIDs, respectively.
86 SxOA on all-cause mortality through either a walking disability or NSAIDs use was 1.92 (95% CI: 0.86-
87 from knee SxOA was mediated mainly through a walking disability.
88 rdiac index >/=2.5 L.min(-1).m(-2), 6-minute walk distance >440 m, and New York Heart Association cla
89  on respiratory-related impairment (6-minute-walk distance <350 m, modified Medical Research Council
90 th placebo, itMSC therapy increased 6-minute walk distance (+36.47 m, 95% confidence interval 5.98-66
91 ith PAD had a significantly shorter 6-minute-walk distance (356 [108] vs. 422 [103] m, P < 0.001) and
92 onsense mutation DMD and a baseline 6-minute walk distance (6MWD) of 150 m or more and 80% or less of
93 ength and physical performance) and 6-minute walk distance (6MWD), London Chest Activity of Daily Liv
94 95% CI, 0.529 to 1.374; P < 0.001), 6-minute-walk distance (adjusted beta = -10.412; 95% CI, -12.267
95 trozole significantly increased the 6-minute-walk distance (median change = +26 m) compared with plac
96   The primary outcome was change in 6-minute walk distance at 12-week follow-up (minimum clinically i
97 y outcome measure was the change in 6-minute walk distance at the 6-month follow-up.
98 ill exercise significantly improved 6-minute walk distance compared with attention control + placebo,
99 therapy with >/=75-m improvement in 6-minute walk distance compared with patients assigned to optimal
100 M-CSF did not significantly improve 6-minute walk distance more than exercise alone (mean difference,
101 ance (PVR) of at least 400 dyn.s/cm(5) and a walk distance of 150-450 m in 6 min were randomly assign
102      Six-month mean (SE) changes in 6-minute walk distance were 4.6 (8.1) m for the 125-mg resveratro
103 spitalizations, and percent changes in 6-min walk distance) at 6 months.
104 HF-specific quality of life scores, 6-minute walk distance, and NT-proBNP (N-terminal pro-B-type natr
105 ervised treadmill exercise improves 6-minute walk distance, compared with exercise alone and compared
106                                 The 6-minute-walk distance, health status (St. George's Respiratory Q
107 Secondary end points were change in 6-minute walk distance, plasma N-terminal pro-B-type natriuretic
108   Changes in FEV1, residual volume, 6-minute-walk distance, St. George's Respiratory Questionnaire sc
109 erate PA correlated positively with 6-minute-walk distance.
110 ng LRF using weight (>/=5% reduction), 6-min-walking distance (>/=10% improvement), and urinary cotin
111  patients demonstrating an increase in their walking distance (median percentage increase of the enti
112  distance (less than versus more than median walking distance, or slow walker versus fast walker) was
113 New York Heart Assocation class and 6-minute walking distance, were assessed.
114 x, smoking status, alcohol use, daily blocks walked, diuretic use, estimated glomerular filtration ra
115  respiratory and cardiovascular responses of walking down a busy street with high levels of pollution
116  and wheeze (4.00, 1.52-10.50; p<0.05) after walking down Oxford Street compared with Hyde Park.
117 ng things on a crowded shelf), mobility (ie, walking down steps, stairs, or curbs), and driving.
118                                   Mean daily walking duration and distance were not associated with c
119 displacement of the CoM on oxygen uptake and walking economy without imposing altered gait patterns.
120 (sacrum marker displacement), oxygen uptake, walking economy, stride characteristics and lower limb j
121 ompanied by an increase in oxygen uptake and walking economy.
122 determinants of gait do not serve to improve walking economy.
123                                           To walk efficiently over complex terrain, humans must use v
124 e perceived availability of healthy food and walking environment were assessed via surveys, and 1-mil
125 -third of all stroke survivors are unable to walk, even after intensive physiotherapy.
126 normal physical activity (control; n=145) or walking exercise (n=151); 227 patients (exercise n=104;
127                                              Walking exercise may augment the effects of GM-CSF in PA
128 trial to test whether a simple, personalized walking exercise program at home, managed by dialysis st
129  walking locations was assessed according to walking exposure (duration, distance, and intensity) and
130         HIT'nDRIVE aims to solve the "random walk facility location" (RWFL) problem in a gene (or pro
131  imaging and electrophysiology in head-fixed walking flies to identify a different neural population
132 ving, but not slow-moving, visual stimuli in walking flies.
133 pairs of cells migrate as a diffusive random walk for at least 7 hours of evolution.
134            Data were collected on ability of walking for 1 kilometer and use of NSAIDs at baseline an
135 reas with low pedestrian collision risk when walking for recreation, walking at a faster pace, or tak
136 ient experimental approaches (especially ALN-walking) for CNV breakpoint sequencing and highlights th
137 try linker-mediated nested PCR walking' (ALN-walking) for CNV breakpoint sequencing in 49 subjects wi
138 " the expected length of the shortest random walk from any one of the set of sequence-altered genes t
139 ted state in the Markov chain, take a random walk from the presented state for any number of steps.
140 ion [staff dedicated to assist transfers and walking from postoperative days (PODs) 0-3].
141 arwin, but the origins of humans' economical walking gait and endurance running capabilities remain u
142                                  PwP able to walk &gt;/=100 m and with no contraindication to exercise w
143                              However, during walking, humans need to adapt these parameters at every
144 ements of participants were taken before the walk in the hospital laboratory.
145                       Participants typically walked in areas with low pedestrian collision risk when
146 med extensor torque to the knee joint during walking in a multi-week exploratory clinical study.
147 e mechanical work production during barefoot walking in a segment-by-segment manner (hallux, forefoot
148  with high levels of pollution compared with walking in a traffic-free area with lower pollution leve
149 pants, irrespective of their disease status, walking in Hyde Park led to an increase in lung function
150  the MV would affect sway variability during walking in older adults.
151  recordings directly comparing bicycling and walking in Parkinson disease patients with electrodes im
152 scillatory dynamics underlying bicycling and walking in the basal ganglia.
153 e microtubules in cells and suppresses motor walking in vitro.
154               Energy expenditure (EE) during walking includes energy costs to move and support the bo
155      Post-intervention, VO2 peak during race walking increased in all groups (P < 0.001, 90% CI: 2.55
156            SPG5 patients lost the ability to walk independently after a median disease duration of 23
157 d over, 11 fed orally and could speak, and 2 walked independently.
158 tic analysis using networks, based on random walks, information diffusion and electrical resistance.
159 essed the effectiveness of a pedometer-based walking intervention in predominantly inactive adults, d
160                Freely flying bees trained to walk into a miniature Y-maze displaying these stimuli in
161 ate is an [Formula: see text]-outlier on the walk is significant at [Formula: see text] under the nul
162 EY POINTS: The vestibular influence on human walking is phase-dependent and modulated across both lim
163 without freezing of gait, both bicycling and walking led to a suppression of subthalamic beta power (
164 orpius-type claspers on the first and second walking legs in male individuals of Y. luopingensis indi
165  of pedestrian-vehicle collision in specific walking locations was assessed according to walking expo
166 age during an hourly observation, parks with walking loops had 80% more users (95% CI: 42, 139%), and
167                    The prevalence and use of walking loops in neighborhood parks: a national study.
168                  Here we describe the use of walking loops in parks and compare the number of park us
169                                              Walking loops may be a promising means of increasing pop
170         Overall, compared with parks without walking loops, on average during an hourly observation,
171 in urban neighborhood parks with and without walking loops.
172 n of mechanical ventilation), and ability to walk (measured by GBS disability score).
173 he ROI images by applying an improved random walk method based on automatic seed generation.
174          Our results suggest that the random walk model can act as a useful predictive tool for descr
175 ethods, we developed a global network random walk model for predicting lncRNA-disease associations (G
176                                       Random walk modelling of herpes simplex virus 1-sized particles
177                                     The jump-walking Monte-Carlo algorithm is revisited and updated t
178 acebo and whether exercise improves 6-minute walk more than an attention control intervention.
179        GM-CSF alone did not improve 6-minute walk more than attention control + placebo (mean differe
180 rmine whether GM-CSF alone improves 6-minute walk more than placebo and whether exercise improves 6-m
181 ong-term frequency drifts governed by random-walk-noise statistics.High-quality optical resonators ha
182 ct's gait was recorded in a gait laboratory, walking normally, with 5 degrees and 10 degrees LWIs, to
183                                            A walk of (S)-GNA along the guide and passenger strands of
184 t observed Pd-catalyzed isomerization ("cage-walking") of B(9)-bromo-meta-carborane during Pd-catalyz
185                         Here, human subjects walked on a split-belt treadmill with one belt moving at
186 ve that a group of anonymous agents randomly walking on a grid are able to estimate their density wit
187 ed visual environment in which tethered bees walking on a spherical treadmill learn to discriminate v
188 s this issue in the context of adaptation to walking on a split-belt treadmill, which can impose a le
189 ry is the energetically optimal strategy for walking on a split-belt treadmill.
190 ivity from areas 5b and 7 of the PPC of cats walking on a treadmill and stepping over a moving obstac
191 tidirectional waist-pull perturbations while walking on a treadmill.
192 e beneficial responses were attenuated after walking on Oxford Street.
193 r rapidly in everyday activity, such as when walking on sand, suggests the existence of long-term mot
194 n supraspinal structures as is the case when walking on targets.
195 d kinematic locomotor characteristics during walking on the FTM and LTM.
196 quence of images generated by three distinct walks on a modular network.
197 ns including the motion of a myosin-V dimer "walking" on an actin fibre, RNA stem-loop packing, and t
198                       We developed a nuclear walk-on assay that semi-globally quantifies nascent tran
199 raffic flows) rather than the probability of walking or biking (i.e., "walkability" or "bikeability")
200 mb occurs rapidly at the onset of split-belt walking, over a shorter time course relative to the char
201 ng respondents to walk 2.5 m at their normal walking pace.
202     Presenting symptoms were difficulties in walking, pain during exercise, delayed motor milestones
203                            The goal-directed walking paradigm reported here, based on full-body motio
204  crouch gait, a debilitating and inefficient walking pattern marked by excessive knee flexion that wo
205 nting sensory signals from destabilizing the walking pattern.
206                                              Walking patterns were superimposed onto maps of the hist
207  125 mg/d or 500 mg/d, improves the 6-minute walk performance in patients with peripheral artery dise
208 bility (trunk composite strength: six-minute walk performance, chair stand test, Berg balance perform
209 tional ability (rectus abdominis: six-minute walk performance, chair stand test, sitting and rising t
210 whereas GM-CSF did not significantly improve walking performance, either when used alone or when comb
211                   The mean overall distances walked pre- and post-TAVR (6 months post-TAVR) were 204+
212 ent self-reported estimates of the distances walked prior to acute illness are subjective and may be
213                       Ultimately, this "cage-walking" process provides a unique pathway to preferenti
214 ltimeric assemblies, the controllable motors walk processively along actin filaments at speeds of 10-
215                                      Kinesin walks processively on microtubules (MTs) in an asymmetri
216  myosin superfamily that, upon dimerization, walks processively toward the pointed end of the actin f
217 tervention groups received pedometers, 12-wk walking programmes, and PA diaries.
218 n changing speed.SIGNIFICANCE STATEMENT When walking, receptors located in the skin respond to mechan
219 3-18], the neuronal underpinnings of evasive walking remain largely unexplored.
220 to investigate how PD affects the ability to walk, respond to balance perturbations, and produce acut
221 tions between individuals' walking bouts and walking risk, measured as mean exposure to the risk of p
222 space of "landing probabilities" of a random walk rooted at the seed set, ranking nodes according to
223                              The "Read-Split-Walk" (RSW) and "Read-Split-Run" (RSR) methods were deve
224 ] age, 63.0 [8.2] years) and 1461 adults had walking scores at baseline indicating adequate function
225                                  During each walk session, black carbon, particulate matter (PM) conc
226     It is demonstrated that the updated jump-walking simulations are able to produce equilibrium isot
227  strength, low physical activity, and slowed walk speed (19.4%).
228 d poor grip strength, exhaustion, and slowed walking speed (hazard ratio, 2.61; 95% CI, 1.14-5.97) we
229     KT recipients with exhaustion and slowed walking speed (hazards ratio = 2.43; 95% CI, 1.17-5.03)
230 ength (Spearman r=-0.34, P<0.01), and slower walking speed (Spearman r=-0.30, P<0.05).
231 h grip strength (Spearman r=-0.57, P<0.005), walking speed (Spearman r=-0.47, P<0.005), and falls (Sp
232 essed as a binary yes or no outcome) or slow walking speed (yes or no) during the 4-year follow-up pe
233 the onset of MLR-HFS, a significantly higher walking speed and improvements in several dynamic gait p
234            However, (3) interactions between walking speed and susceptibility to perturbations, when
235 od of developing weak grip strength and slow walking speed because purpose has been linked with a ran
236 sk of developing weak grip strength and slow walking speed over time.
237 , although the findings were more robust for walking speed than for grip strength.
238 g Smedley spring-type hand dynamometers, and walking speed was assessed by asking respondents to walk
239                            Associations with walking speed were maintained in all covariate models (f
240 sk of developing weak grip strength and slow walking speed, although the findings were more robust fo
241  impaired activities of daily living, faster walking speed, and favorable objective biomarkers (conce
242  grip strength, poorer lung function, slower walking speed, lower fluid intelligence, higher allostat
243 onal Composite score (a composite measure of walking speed, upper-limb movements, and cognition; for
244 sed risk (95% CI, 8%-20%) of developing slow walking speed.
245 ctivity in the 20-40 Hz range in resting and walking states, and increased interhemispheric coupling
246            LFPs were recorded in resting and walking states, before and after unilateral 6-hydroxydop
247 ractant not only by biasing their own random-walk swimming pattern through the well-understood intrac
248                 Recently, we developed a DNA walking system for the detection and characterization of
249 roughput and sensitivity by coupling the DNA walking system to Pacific Bioscience(R) Next-generation
250 otein and genetic interactions, using random walk techniques.
251 f 45; P = 0.006) and improvement in 6-minute-walk test (+20.6 m vs. -25.0 m; P = 0.017) at Day 84.
252 rcise capacity was evaluated by the 6-minute walk test (6MWT).
253  exercise capacity as documented by 6-minute walk test (6MWT).
254 ressive symptoms (P=0.027), and the 6-minute walk test (P=0.012).
255 (muscle and/or nerve function), and 6-minute-walk test (physical function).
256 art Failure Questionnaire [MLHFQ], and 6-min walk test [6MWT]) were performed at baseline and 30 days
257 as no significant difference in the 6-minute walk test between the inpatient rehabilitation and eithe
258          The effects on BODE index, 6-minute-walk test distance (6MWD), and health-related quality of
259 ore increased (mean: 43.1 to 77.0) and 6-min walk test distance results increased (mean: 163.6 to 252
260 to treatment was assessed using the 6-minute walk test distance, which increased in 25 subjects and d
261                                    The 6-min walk test increased with allo-hMSCs by 37.0 m (p = 0.04)
262 block method stratified by baseline 6-minute walk test performance.
263 operative functional walking capacity (6-min walk test) at 4 weeks after surgery.
264 ellar Functional System score, Timed 25-Foot Walk Test, 9-Hole Peg Test (9-HPT), Symbol Digit Modalit
265 aphy, magnetic resonance imaging, a 6-minute walk test, and measurement of natriuretic peptides befor
266 res, and 4990 (10.2%) completed the 6-minute walk test, made available only at the end of 7 days.
267 ving with Heart Failure Questionnaire, 6-min walk test, major adverse cardiac events, and immune biom
268 ks after surgery, measured with the 6-minute walk test.
269 lth questionnaires, and completed a 6-minute walk test.
270  assessed using clinical scoring of the beam-walking test and video-kinematic analysis (CatWalk) at b
271     The distance covered during the 6-minute walking test improved in the exercise group (mean distan
272 ht-sided heart catheterization, and 6-minute walk testing with a median follow-up of 4.0 years.
273 is effect was eliminated in a highly regular walk that sampled exhaustively from images in short, suc
274  formulation and analysis of the "ability to walk the derivative chromosome" signature originally pro
275                             ABSTRACT: During walking, the vestibular influence on locomotor activity
276          Long before infants reach, crawl or walk, they explore the world by looking: they look to le
277                  Frailty was measured by 4-m walk time, grip strength, self-reported weight loss, exh
278 ere change from baseline to 6 months in peak walking time (PWT), collateral count, peak hyperemic pop
279 month mean (SE) changes in maximal treadmill walking time were 0.5 (2.3) minutes for the 125-mg resve
280 ary outcomes was change in maximal treadmill walking time.
281 bute to speed-dependent gait transition from walk, to trot, and then to gallop and bound; the homolat
282 ell motility inside the aggregates, a biased walk toward aggregate centroids, and alignment among nei
283 ach subtype at the start and end of tethered-walking turns.
284 f 53, P < .001) IVIG treatment, inability to walk unaided (21 [35.0%] of 60 vs 6 [5.3%] of 114, P < .
285                        We measured EE during walking under three different oxygen concentrations.
286                                              Walks varied along two critical dimensions: their predic
287 pothesized that LC16 neurons induce backward walking via MDNs and that turning while walking backward
288     We found that the swing phase during LTM walking was slightly enhanced as well as some specific a
289 r adjustments affect amputees more when they walk with (versus without) load.
290 al cord or after a unilateral hemisection to walk with a precise foot placement on the rungs fixed to
291        Quadrupeds, like most bipeds, tend to walk with an even left/right footfall timing.
292 develop self-organizing map (SOM) and random walk with restart (RWR) algorithms to separate the proge
293                   Five transfemoral amputees walked with and without load (i.e. weighted backpack) an
294 ics of cortical involvement in human upright walking with a closed-loop BCI has not been investigated
295 erences in cortical network activity between walking with and without closed-loop BCI control.
296 ing increases of cortical involvement during walking with BCI control.
297                  Primary outcome was a 2 min walk, with motor symptoms (Movement Disorder Society Uni
298    The robot is designed to perform a random walk without any energy supply.
299 ity and base of support were evaluated while walking without cables and reacting to the perturbations
300 y week 120, performance on the timed 25-foot walk worsened by 38.9% with ocrelizumab versus 55.1% wit

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top